MoneyWorks4Me

Orchid Pharma informs about investor roadshow

04 Jun 2024 Evaluate
Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Orchid Pharma has informed that Mridul Dhanuka, Whole Time Director of Orchid Pharma (the Company) will be participating in Roadshows scheduled to be held as per the details enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1851.05
Dr. Reddys Labs. 1141.00
Cipla 1358.80
Lupin 2042.20
Zydus Lifesciences 1097.55
View more..